Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Deacetyltaxol, also known as a semi-synthetic precursor of Paclitaxel, is a taxane derivative obtained from Catharanthus roseus. It is a white to off-white solid with unique chemical properties that make it a valuable compound in the pharmaceutical industry.

78432-77-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Benzenepropanoic acid, b-(benzoylamino)-a-hydroxy-,(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetram

    Cas No: 78432-77-6

  • USD $ 10.0-10.0 / Gram

  • 1 Gram

  • 10 Metric Ton/Day

  • LIDE PHARMACEUTICALS LIMITED
  • Contact Supplier
  • 78432-77-6 Structure
  • Basic information

    1. Product Name: Deacetyltaxol
    2. Synonyms: 10-DEACETYL PACLITAXEL;10-DEACETYLTAXOL;DEACETYLTAXOL;10-Desacetyl Paclitaxel;10-Desacetyltaxol;10-O-Deacetyltaxol;7-EPI-10-DEACETYL PACLITAXEL;b-(Benzoylamino)-a-hydroxy-benzenepropanoic acid [2aR-[2aa,4b,4ab,6b,9a(aR*,bS*),11a,12a,12aa,12ba]]-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester
    3. CAS NO:78432-77-6
    4. Molecular Formula: C45H49NO13
    5. Molecular Weight: 811.87
    6. EINECS: N/A
    7. Product Categories: Miscellaneous Biochemicals;Intermediates & Fine Chemicals;Pharmaceuticals;chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract;Inhibitors
    8. Mol File: 78432-77-6.mol
  • Chemical Properties

    1. Melting Point: 182-184?C
    2. Boiling Point: 959.5 °C at 760 mmHg
    3. Flash Point: 534.1 °C
    4. Appearance: /
    5. Density: 1.41 g/cm3
    6. Vapor Pressure: 0mmHg at 25°C
    7. Refractive Index: 1.652
    8. Storage Temp.: -20°C Freezer
    9. Solubility: Chloroform (Slightly), Methanol (Slightly)
    10. PKA: 11.31±0.70(Predicted)
    11. CAS DataBase Reference: Deacetyltaxol(CAS DataBase Reference)
    12. NIST Chemistry Reference: Deacetyltaxol(78432-77-6)
    13. EPA Substance Registry System: Deacetyltaxol(78432-77-6)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: 24/25
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 78432-77-6(Hazardous Substances Data)

78432-77-6 Usage

Uses

Used in Pharmaceutical Industry:
Deacetyltaxol is used as a semi-synthetic precursor for the production of Paclitaxel, a widely used chemotherapeutic drug. It plays a crucial role in the synthesis of Paclitaxel, which is effective against various types of cancer, including ovarian, breast, and lung cancer.
Used in Cancer Treatment:
Deacetyltaxol is used as an intermediate in the production of Paclitaxel, which is employed as a chemotherapeutic agent for the treatment of various cancers. Its ability to stabilize microtubules and inhibit cell division makes it a potent anticancer drug.
Used in Drug Development:
Deacetyltaxol serves as a key component in the development of new drugs and therapies. Its unique chemical properties and potential to be modified or combined with other compounds make it a valuable asset in the search for novel cancer treatments and other therapeutic applications.

Check Digit Verification of cas no

The CAS Registry Mumber 78432-77-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,8,4,3 and 2 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 78432-77:
(7*7)+(6*8)+(5*4)+(4*3)+(3*2)+(2*7)+(1*7)=156
156 % 10 = 6
So 78432-77-6 is a valid CAS Registry Number.
InChI:InChI=1/C45H49NO13/c1-24-29(57-41(54)35(50)33(26-15-9-6-10-16-26)46-39(52)27-17-11-7-12-18-27)22-45(55)38(58-40(53)28-19-13-8-14-20-28)36-43(5,37(51)34(49)32(24)42(45,3)4)30(48)21-31-44(36,23-56-31)59-25(2)47/h6-20,29-31,33-36,38,48-50,55H,21-23H2,1-5H3,(H,46,52)/t29-,30-,31+,33-,34+,35+,36-,38-,43+,44-,45+/m0/s1

78432-77-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name Deacetyltaxol

1.2 Other means of identification

Product number -
Other names 10-DAT

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:78432-77-6 SDS

78432-77-6Synthetic route

dihydrogen peroxide
7722-84-1

dihydrogen peroxide

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

Conditions
ConditionsYield
With sodium hydrogencarbonate In tetrahydrofuran96%
10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

Conditions
ConditionsYield
With dihydrogen peroxide; sodium hydrogencarbonate In tetrahydrofuran for 24h; Ambient temperature;95%
C51H51Cl6NO17
114915-18-3

C51H51Cl6NO17

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

Conditions
ConditionsYield
With acetic acid; zinc In methanol at 60℃; for 2h;90%
With acetic acid; zinc In methanol

A

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

B

7-Epi-10-Deacetylpaclitaxel

7-Epi-10-Deacetylpaclitaxel

Conditions
ConditionsYield
With zinc dibromide In methanol for 48h; Ambient temperature;A 36%
B 29%
With water; scandium tris(trifluoromethanesulfonate) In methanol at 40℃; for 72h; Deacetylation;
7-O-(β-xylosyl)-10-deacetyltaxol

7-O-(β-xylosyl)-10-deacetyltaxol

A

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

B

7-Epi-10-Deacetylpaclitaxel

7-Epi-10-Deacetylpaclitaxel

Conditions
ConditionsYield
With Enterobacter sp. CGMCC 2487 In N,N-dimethyl-formamide at 26℃; for 216h; pH=6; PBS buffer; Microbiological reaction;A 29%
B 6.9%
7-α-glucosyloxyacetyl paclitaxel
197013-82-4

7-α-glucosyloxyacetyl paclitaxel

A

10-deacetylbaccatin III
32981-86-5

10-deacetylbaccatin III

B

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

C

taxol
33069-62-4

taxol

D

7-epipaclitaxel
105454-04-4

7-epipaclitaxel

Conditions
ConditionsYield
With Marchantia polymorpha; BG-11 medium at 25℃; Further byproducts.;A 8%
B 10%
C 17%
D 8%
7-α-glucosyloxyacetyl paclitaxel
197013-82-4

7-α-glucosyloxyacetyl paclitaxel

A

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

B

taxol
33069-62-4

taxol

Conditions
ConditionsYield
With Glycine max; BG-11 medium at 25℃;A 6%
B 16%
7-Acetyl-10-deacetyltaxol

7-Acetyl-10-deacetyltaxol

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

Conditions
ConditionsYield
With dihydrogen peroxide; sodium hydrogencarbonate In tetrahydrofuran Ambient temperature;
7-O-(β-xylosyl)-10-deacetyltaxol

7-O-(β-xylosyl)-10-deacetyltaxol

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

Conditions
ConditionsYield
With sodium periodate; sulfuric acid; acetic acid; phenylhydrazine 1.) DMF, 3 h, 2.) 60 deg C, 3 h; Yield given. Multistep reaction;
Stage #1: 7-O-(β-xylosyl)-10-deacetyltaxol With sodium periodate; sulfuric acid In methanol; chloroform; water at 20℃; for 3h;
Stage #2: With acetic acid; phenylhydrazine In methanol; water at 50℃; for 2h;
Stage #1: 7-O-(β-xylosyl)-10-deacetyltaxol With sodium periodate; sulfuric acid In methanol; chloroform at 20℃; for 3h;
Stage #2: With acetic acid; phenylhydrazine In methanol at 50℃; for 2h;
With recombinant β-xylosidase Dt-xyl3 from Dictyoglomus turgidum In aq. phosphate buffer; dimethyl sulfoxide at 60℃; for 0.5h; pH=4.5; Kinetics; Catalytic behavior; Reagent/catalyst; Temperature; pH-value; Concentration; Enzymatic reaction;
C47H50ClNO14

C47H50ClNO14

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

Conditions
ConditionsYield
With methanol at 20℃; Solvolysis;

A

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

B

7-epi-paclitaxel

7-epi-paclitaxel

C

baccatin III

baccatin III

Conditions
ConditionsYield
With α-tocopherylpolyethyleneglycol-100 succinate; poloxamer 407; Tocopherol In water at 4℃; for 7305h; Product distribution; Further Variations:; Temperatures; time of storage;
10-deacetyl-7,10-diTroc-baccatin III
114915-16-1

10-deacetyl-7,10-diTroc-baccatin III

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: pyridine / 3 h / Ambient temperature
2: 90 percent / Zn, AcOH / methanol / 2 h / 60 °C
View Scheme
benzoyl chloride
98-88-4

benzoyl chloride

O5-benzoyl-O1,O2-isopropyliden-β-D-arabinofuranose

O5-benzoyl-O1,O2-isopropyliden-β-D-arabinofuranose

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: pyridine / 3 h / Ambient temperature
2: 90 percent / Zn, AcOH / methanol / 2 h / 60 °C
View Scheme
7,10-bis-O-(2,2,2-trichloroethoxycarbonyl)docetaxel
114915-14-9

7,10-bis-O-(2,2,2-trichloroethoxycarbonyl)docetaxel

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 75 percent / ISi(CH3)3 / acetonitrile / 0.5 h / 0 °C
2: pyridine / 3 h / Ambient temperature
3: 90 percent / Zn, AcOH / methanol / 2 h / 60 °C
View Scheme
7-O-(β-xylosyl)-10-deacetyltaxol

7-O-(β-xylosyl)-10-deacetyltaxol

A

7-β-D-xylosylbaccatin III
157664-03-4

7-β-D-xylosylbaccatin III

B

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

C

7-Epi-10-Deacetylpaclitaxel

7-Epi-10-Deacetylpaclitaxel

Conditions
ConditionsYield
With Enterobacter sp. CGMCC 2487 pH=8; PBS buffer; Microbiological reaction;
(2'R,3

(2'R,3"S)-2'-(2-methoxy-2-propyloxy)-7-triethylsilyl taxol

A

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

B

taxol
33069-62-4

taxol

C

7-O-(triethylsilyl)paclitaxel
148930-55-6

7-O-(triethylsilyl)paclitaxel

D

7-epipaclitaxel
105454-04-4

7-epipaclitaxel

Conditions
ConditionsYield
With trifluoroacetic acid In water; acetic acid at 20℃; for 6h; Solvent; Reagent/catalyst; Concentration; Time;
7-xylosyl-10-deacetyl taxol

7-xylosyl-10-deacetyl taxol

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

Conditions
ConditionsYield
at 30 - 55℃; for 12h;
10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

10-deacetyl-9β-hydroxypaclitaxel

10-deacetyl-9β-hydroxypaclitaxel

Conditions
ConditionsYield
With samarium diiodide; 1,2-Diiodoethane; acetic acid In tetrahydrofuran at -5℃; for 1h;83%
acetic anhydride
108-24-7

acetic anhydride

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

Conditions
ConditionsYield
Stage #1: 10-deacetylpaclitaxel With Chloroacetamide In tetrahydrofuran at 100℃; for 3h;
Stage #2: acetic anhydride In tetrahydrofuran at 100℃; for 3h;
Stage #3: With methanol; sodium hydrogencarbonate; thiourea at 20℃; for 1h; Product distribution / selectivity;
78.8%
Stage #1: 10-deacetylpaclitaxel With pyridine; Chloroacetamide at 20℃; for 1h;
Stage #2: acetic anhydride With pyridine In tetrahydrofuran at 100℃; for 0.5h;
Stage #3: With methanol; sodium hydrogencarbonate; thiourea at 20℃; for 1h; Product distribution / selectivity;
60%
Stage #1: 10-deacetylpaclitaxel With Chloroacetamide In tetrahydrofuran at 100℃; for 3h;
Stage #2: acetic anhydride In tetrahydrofuran at 100℃; for 3h;
Stage #3: With sodium hydrogencarbonate; thiourea In methanol at 20℃; for 1h; Product distribution / selectivity;
butanoic acid anhydride
106-31-0

butanoic acid anhydride

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

propionic acid
802294-64-0

propionic acid

C52H59NO15

C52H59NO15

Conditions
ConditionsYield
Multistep reaction.;71%
butanoic acid anhydride
106-31-0

butanoic acid anhydride

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

C49H55NO14

C49H55NO14

Conditions
ConditionsYield
Stage #1: 10-deacetylpaclitaxel With 1H-imidazole; chlorinated PS-DES resin In dichloromethane at 20℃; for 24h;
Stage #2: butanoic acid anhydride With cerium(III) chloride In tetrahydrofuran at 20℃; for 24h;
Stage #3: With pyridine; hydrogen fluoride In tetrahydrofuran at 20℃; for 2h; Further stages.;
69%
10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

propionic acid anhydride
123-62-6

propionic acid anhydride

chloroacetic acid
79-11-8

chloroacetic acid

C50H54ClNO15

C50H54ClNO15

Conditions
ConditionsYield
Multistep reaction.;69%
10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

propionic acid anhydride
123-62-6

propionic acid anhydride

benzoic acid
65-85-0

benzoic acid

C55H57NO15

C55H57NO15

Conditions
ConditionsYield
Multistep reaction.;66%
10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

chloroacetic acid
79-11-8

chloroacetic acid

C17H14O5

C17H14O5

C55H56ClNO16

C55H56ClNO16

Conditions
ConditionsYield
Multistep reaction.;66%
10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

benzoic acid
65-85-0

benzoic acid

C17H14O5

C17H14O5

C62H63NO14

C62H63NO14

Conditions
ConditionsYield
Multistep reaction.;64%
10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

propionic acid anhydride
123-62-6

propionic acid anhydride

valeric acid
109-52-4

valeric acid

C53H61NO15

C53H61NO15

Conditions
ConditionsYield
Multistep reaction.;62%
10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

3-Methoxybenzoic acid
586-38-9

3-Methoxybenzoic acid

benzoic acid anhydride
93-97-0

benzoic acid anhydride

C60H59NO16

C60H59NO16

Conditions
ConditionsYield
Multistep reaction.;62%
10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

benzoic acid anhydride
93-97-0

benzoic acid anhydride

chloroacetic acid
79-11-8

chloroacetic acid

C54H54ClNO15

C54H54ClNO15

Conditions
ConditionsYield
Multistep reaction.;61%
10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

C17H14O5

C17H14O5

C53H55NO15

C53H55NO15

Conditions
ConditionsYield
Stage #1: 10-deacetylpaclitaxel With 1H-imidazole; chlorinated PS-DES resin In dichloromethane at 20℃; for 24h;
Stage #2: C17H14O5 With cerium(III) chloride In tetrahydrofuran at 20℃; for 24h;
Stage #3: With pyridine; hydrogen fluoride In tetrahydrofuran at 20℃; for 2h; Further stages.;
60%
10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

benzoic acid anhydride
93-97-0

benzoic acid anhydride

C52H53NO14

C52H53NO14

Conditions
ConditionsYield
Stage #1: 10-deacetylpaclitaxel With 1H-imidazole; chlorinated PS-DES resin In dichloromethane at 20℃; for 24h;
Stage #2: benzoic acid anhydride With cerium(III) chloride In tetrahydrofuran at 20℃; for 24h;
Stage #3: With pyridine; hydrogen fluoride In tetrahydrofuran at 20℃; for 2h; Further stages.;
60%
crotonic anhydride
623-68-7

crotonic anhydride

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

cyclopropanecarboxylic acid
1759-53-1

cyclopropanecarboxylic acid

C53H57NO15

C53H57NO15

Conditions
ConditionsYield
Multistep reaction.;59%
10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

propionic acid
802294-64-0

propionic acid

C17H14O5

C17H14O5

C56H59NO16

C56H59NO16

Conditions
ConditionsYield
Multistep reaction.;59%
10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

propionic acid
802294-64-0

propionic acid

propionic acid anhydride
123-62-6

propionic acid anhydride

C51H57NO15

C51H57NO15

Conditions
ConditionsYield
Multistep reaction.;59%
3-Methylbutenoic acid
541-47-9

3-Methylbutenoic acid

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

benzoic acid anhydride
93-97-0

benzoic acid anhydride

C57H59NO15

C57H59NO15

Conditions
ConditionsYield
Multistep reaction.;59%
10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

propionic acid anhydride
123-62-6

propionic acid anhydride

butyric acid
107-92-6

butyric acid

C52H59NO15

C52H59NO15

Conditions
ConditionsYield
Multistep reaction.;58%
10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

propionic acid anhydride
123-62-6

propionic acid anhydride

cyclopropanecarboxylic acid
1759-53-1

cyclopropanecarboxylic acid

C52H57NO15

C52H57NO15

Conditions
ConditionsYield
Multistep reaction.;58%
10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

benzoic acid anhydride
93-97-0

benzoic acid anhydride

cyclopropanecarboxylic acid
1759-53-1

cyclopropanecarboxylic acid

C56H57NO15

C56H57NO15

Conditions
ConditionsYield
Multistep reaction.;58%
crotonic anhydride
623-68-7

crotonic anhydride

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

benzoic acid
65-85-0

benzoic acid

C56H57NO15

C56H57NO15

Conditions
ConditionsYield
Multistep reaction.;57%
3-Methylbutenoic acid
541-47-9

3-Methylbutenoic acid

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

C17H14O5

C17H14O5

C58H61NO16

C58H61NO16

Conditions
ConditionsYield
Multistep reaction.;56%
crotonic anhydride
623-68-7

crotonic anhydride

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

C49H53NO14

C49H53NO14

Conditions
ConditionsYield
Stage #1: 10-deacetylpaclitaxel With 1H-imidazole; chlorinated PS-DES resin In dichloromethane at 20℃; for 24h;
Stage #2: crotonic anhydride With cerium(III) chloride In tetrahydrofuran at 20℃; for 24h;
Stage #3: With pyridine; hydrogen fluoride In tetrahydrofuran at 20℃; for 2h; Further stages.;
56%
10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

C17H14O5

C17H14O5

cyclopropanecarboxylic acid
1759-53-1

cyclopropanecarboxylic acid

C57H59NO16

C57H59NO16

Conditions
ConditionsYield
Multistep reaction.;56%
crotonic anhydride
623-68-7

crotonic anhydride

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

chloroacetic acid
79-11-8

chloroacetic acid

C51H54ClNO15

C51H54ClNO15

Conditions
ConditionsYield
Multistep reaction.;55%
3-Methylbutenoic acid
541-47-9

3-Methylbutenoic acid

10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

propionic acid anhydride
123-62-6

propionic acid anhydride

C53H59NO15

C53H59NO15

Conditions
ConditionsYield
Multistep reaction.;54%
10-deacetylpaclitaxel
78432-77-6

10-deacetylpaclitaxel

propionic acid anhydride
123-62-6

propionic acid anhydride

paclitaxel

paclitaxel

Conditions
ConditionsYield
Stage #1: 10-deacetylpaclitaxel With 1H-imidazole; chlorinated PS-DES resin In dichloromethane at 20℃; for 24h;
Stage #2: propionic acid anhydride With cerium(III) chloride In tetrahydrofuran at 20℃; for 24h;
Stage #3: With pyridine; hydrogen fluoride In tetrahydrofuran at 20℃; for 2h; Further stages.;
54%

78432-77-6Relevant articles and documents

Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel

Constantinides, Panayiotis P.,Lambert, Karel J.,Tustian, Alex K.,Schneider, Brian,Lalji, Salima,Ma, Wenwen,Wentzel, Bryan,Kessler, Dean,Worah, Dilip,Quay, Steven C.

, p. 175 - 182 (2000)

Purpose. Paclitaxel is currently administered i.v. as a slow infusion of a solution of the drug in an ethanol:surfactant:saline admixture. However, poor solubilization and toxicity are associated with this drug therapy. Alternative drug delivery systems, including parenteral emulsions, are under development in recent years to reduce drug toxicity, improve efficacy and eliminate premedication. Methods. Paclitaxel emulsions were prepared by high- shear homogenization. The particle size of the emulsions was measured by dynamic light scattering. Drug concentration was quantified by HPLC and in vitro drug release was monitored by membrane dialysis. The physical stability of emulsions was monitored by particle size changes in both the mean droplet diameter and 99% cumulative distribution. Paclitaxel potency and changes in the concentration of known degradants were used as chemical stability indicators. Single dose acute toxicity studies were conducted in healthy mice and efficacy studies in B 16 melanoma tumor-bearing mice. Results. QW8184, a physically and chemically stable sub-micron oil-in-water (o/w) emulsion of paclitaxel, can be prepared at high drug loading (8-10 mg/mL) having a mean droplet diameter of a 3-fold increase in the maximum-tolerated-dose (MTD) over the current marketed drug formulation. Using the B16 mouse melanoma model, a significant improvement in drug efficacy was observed with QW8184 over Taxol. Conclusions. QW8184, a stable sub-micron o/w emulsion of paclitaxel has been developed that can be filter-sterilized and administered i.v. as a bolus dose. When compared to Taxol, this emulsion exhibited reduced toxicity and improved efficacy most likely due to the composition and dependent physicochemical characteristics of the emulsion.

Cloning and characterization of the β-xylosidase from Dictyoglomus turgidum for high efficient biotransformation of 10-deacetyl-7-xylosltaxol

Li, Qi,Jiang, Yujie,Tong, Xinyi,Pei, Jianjun,Xiao, Wei,Wang, Zhenzhong,Zhao, Linguo

, (2019/11/11)

With the aim of finding an extracellular biocatalyst that can efficiently remove the C-7 xylose group from 10-deacetyl-7-xylosltaxol, a Dictyoglomus turgidum β-xylosidase was cloned and expressed in Escherichia coli BL21 (DE3). The molecular mass of purified Dt-Xyl3 was approximately 84 kDa. The recombinant Dt-Xyl3 was most active at pH 5.0 and 75 °C, retaining 88% activity at 65 °C for 1 h, and displaying excellent stability over pH 4.0–7.5 for 24 h. In terms of kinetic parameters, the Km and Vmax values for pNPX were 0.8316 mM and 5.0178 μmol/mL·min, respectively. Moreover, Dt-Xyl3 was activated by Mn2+ and Ba2+ and inhibited by Cu2+, Ni+ and Al3+. In particular, it displayed high tolerance to salts with 60.8% activity in 20% (w/v) NaCl. Ethanol and methanol at 5–15% showed little effect on the enzymatic activity. Dt-Xyl3 demonstrated multifunctional activities followed by pNPX, pNPAraf and pNPG and had a high selectivity for cleaving the outer xylose moieties of 10-deacetyl-7-xylosltaxol with Kcat/Km 110.87 s?1/mM, which produced 10-deacetyl-taxol to semi-synthesize paclitaxel. Under the optimized conditions (60 °C, pH 4.5, enzyme dosage of 0.5 U/mL), 1 g of 10-deacetyl-7-xylosltaxol was transformed to its corresponding aglycone 10-deacetyl-taxol within 30 min, with a molar conversion of 98%. This is the first report that Dictyoglomus turgidum can produce extracellular GH3 β-xylosidase with highly specific activity for 10-deacetyl-7-xylosltaxol biotransformation, thus leading to the application of β-xylosidase Dt-Xyl3 as a biocatalyst in biopharmaceutics.

Glycosyl hydrolase with beta-xylosidase and beta-glucosidase activities and uses thereof

-

Paragraph 18, (2015/12/26)

A novel glycosyl hydrolase with activities of beta-xylosidase and beta-glucosidase is provided. Said glycosyl hydrolase can convert 7-xylosyltaxane compounds to 7-hydroxyltaxane compounds.

Microbial hydrolysis of 7-xylosyl-10-deacetyltaxol to 10-deacetyltaxol

Wang, Kang,Wang, Tingting,Li, Jianhua,Zou, Jianhua,Chen, Yongqin,Dai, Jungui

experimental part, p. 250 - 255 (2011/10/12)

Enterobacter sp. CGMCC 2487, a bacterial strain isolated from the soil around a Taxus cuspidata Sieb. et Zucc. plant, was able to remove the xylosyl group from 7-xylosyltaxanes. The xylosidase of this strain was an inducible enzyme. In the bioconversion of 7-xylosyl-10-deacetyltaxol (7-XDT) to 10-deacetyltaxol (10-DT), for the purpose of enhancing the conversion efficiency, the effects of NH4+, oat xylan, temperature, pH value, cell density and substrate concentration on the bioconversion have been systematically investigated. 3.0 mM NH4+, 0.6% oat xylan in the media could enhance the yield of 10-DT; the optimum biocatalytic temperature was 26 °C and optimum pH value was 6.0. The highest conversion rate and yield of 10-DT from 7-XDT reached 92% and 764 mg/L, respectively. In addition, the biocatalytic capacity of the cell cultures remained 66.1% after continuous three batches. These results indicate that converting 7-XDT to 10-DT, a useful intermediate for the semisynthesis of paclitaxel or other taxane-based anticancer drugs by a novel bacterial strain, Enterobacter sp. CGMCC 2487, would be an alternative for the practical application in the future.

METHOD FOR THE PREPARATION OF SYNTHESIZED TAXANOIDS

-

Page/Page column 5, (2010/02/17)

The present invention relates to a process for the preparation of synthetic taxanes, which protects C(7)-OH with lanthanon compounds. Its advantages are simple process and firm & reliable binding. Moreover, no C(7)-acylated taxanes are produced in the subsequent steps, and hydrolysis of C(2')-ester groups in acylated products becomes readily controllable. In the process for the preparation of synthetic taxanes, tetrahydrofuran is used in the present invention as a medium for acylation, which not only achieves the same effects as pyridine, but also avoids odor, so as to solve the problem regarding the extremely high requirements for the place of production. The present invention can be used for the preparation of not only semi-synthetic taxane using natural taxanes as raw material, but also full-synthetic taxane.

Biological degradation of taxol by action of cultured cells on 7-acetyltaxol-2″-yl glucoside

Shimoda, Kei,Mikuni, Katsuhiko,Nakajima, Kiyoshi,Hamada, Hatsuyuki,Hamada, Hiroki

, p. 362 - 363 (2008/09/20)

Biodegradation pathways of taxol in cultured cells of Synechocystis sp. PCC 6803, Synechococcus sp. PCC 7942, Marchantia polymorpha, Nicotiana tabacum, and Glycine max were investigated using a water-soluble taxol derivative, 7-ace-tyltaxol-2″-yl glucoside, as the substrate. Although cyanobacteria, Synechocystis sp. PCC 6803 and Synechococcus sp. PCC 7942, and a lower plant, M. polymorpha, catalyzed the epimerization at 7-position of taxol skeleton, no epimerization occurred with higher plants, N. tabacum and G. max. On the other hand, Synechocystis sp. PCC 6803, Synechococcus sp. PCC 7942, M. polymorpha, and N. tabacum catalyzed hydrolysis at 13-position of taxol to give baccatin III and 10-deacetyl baccatin III. Both cyanobacteria cells also deacetylated 7-epi-baccatin III at its 10-position. M. polymorpha and G. max deacetylated at 10-position of taxol. Copyright

Process for the Preparation of Synthetic Taxanes

-

Page/Page column 3, (2008/12/09)

The present invention relates to a process for the preparation of synthetic taxanes, which protects C(7)-OH with lanthanon compounds. Its advantages are simple process and firm & reliable binding. Moreover, no C(7)-acylated taxanes are produced in the subsequent steps, and hydrolysis of C(2′)-ester groups in acylated products becomes readily controllable. In the process for the preparation of synthetic taxanes, tetrahydrofuran is used in the present invention as a medium for acylation, which not only achieves the same effects as pyridine, but also avoids odor, so as to solve the problem regarding the extremely high requirements for the place of production. The present invention can be used for the preparation of not only semi-synthetic taxane using natural taxanes as raw material, but also full-synthetic taxane.

METHOD FOR THE PRODUCTION OF TAXOL AND/OR TAXANES FROM CULTURES OF HAZEL CELLS

-

, (2008/06/13)

Method for the production of taxol and/or taxanes, comprising the steps of: a) inducing the formation of callus from a plant tissue explant, through in vitro culturing in a suitable nutritient medium, b) cultivating the callus in a liquid medium to obtain a cell suspension culture capable of producing taxol and/or taxanes, c) recovering the taxol and/or the taxanes from the cells and/or from the culture medium of the cell suspension obtained from the callus in which the tissue explant is obtained from a plant of the genus Corylus, in particular Corylus avellana.

Trifluoroacetic acid-mediated cleavage of a triethylsilyl protecting group: Application in the final step of the semisynthetic route to paclitaxel (Taxol)

Singh, Ambarish K.,Weaver, Raymond E.,Powers, Gerald L.,Rosso, Victor W.,Wei, Chenkou,Lust, David A.,Kotnis, Atul S.,Comezoglu, F. Taha,Liu, Mark,Bembenek, Kenneth S.,Phan, Bich D.,Vanyo, Dale J.,Davies, Merrill L.,Mathew, Rachel,Palaniswamy, Venkatapuram A.,Li, Wen-Sen,Gadamsetti, Kumar,Spagnuolo, Ciro J.,Winter, William J.

, p. 25 - 27 (2013/09/05)

The final step of the semisynthetic route to paclitaxel involves cleavage of the triethylsilyl (TES) protecting group from the C-7 hydroxyl group. Paclitaxel is an extremely complex molecule, and standard deprotection conditions led to formation of several impurities. Trifluoroacetic acid in aqueous acetic acid was found to be very effective in the cleavage of the TES group without compromising the quality of the product.

Mechanistic considerations pertaining to the solvolysis of paclitaxel analogs bearing ester groups at the C2′ position

Klis, Wieslaw A.,Sarver, Jeffrey G.,Erhardt, Paul W.

, p. 7747 - 7750 (2007/10/03)

Dilute solutions of paclitaxel-related derivatives having chloroacetyl esters in the C2′ position undergo ready methanolysis according to pseudo first-order kinetics while more concentrated solutions appear to be stabilized, possibly by the formation of h

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 78432-77-6